Morphic Shows Potential For An ‘Oral Entyvio’ With Phase IIa Data

 
• By Joseph Haas
Biz competition
Morphic made progress in the race for an oral therapy in UC • Source: Shutterstock

More from Clinical Trials

More from R&D